Skip to main content

Table 1 Clinical characteristics of patients with PCC, SCS, and NFA

From: Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports

 

Total

PCC

SCS

NFA

p value

Kruskal-Wallis

PCC vs SCS

PCC vs NFA

Number

67

18

18

31

   

Age (yr)

57 ± 15

53 ± 19

57 ± 14

59 ± 14

0.404

Sex (males/females)

28 / 39

7 / 11

6 / 12

15 / 16

0.564

Body Mass Index (kg/m2)

23.1 ± 4.1

21.0 ± 3.3*

24.9 ± 4.7*

23.3 ± 3.7

0.023

0.019

0.256

Systolic blood pressure (mmHg)

127 ± 19

126 ± 20

132 ± 12

126 ± 22

0.372

Diastolic blood pressure (mmHg)

74 ± 11

72 ± 9

77 ± 11

73 ± 12

0.370

Antihypertensive Drugs (%)

 CCB

25 (37%)

5 (28%)

8 (44%)

12 (39%)

0.572

 α blocker

7 (10%)

3 (17%)

2 (11%)

2(6%)

0.527

  1. CCB Calcium channel blocker, PCC pheochromocytoma, SCS subclinical cushing syndrome, NFA Non-functioning adrenal tumor
  2. Data are expressed as mean ± S.D. *p <0.05 compared between group of PCC and SCS